MS

Manuel Schmidt

MA Mologen Ag: 8 patents #2 of 18Top 15%
GS Gilead Sciences: 2 patents #483 of 952Top 55%
Overall (All Time): #446,657 of 4,157,543Top 15%
11
Patents All Time

Issued Patents All Time

Showing 1–11 of 11 patents

Patent #TitleCo-InventorsDate
11583581 Methods of treating a retroviral infection Matthias Schroff, Kerstin Kapp, Alfredo Zurlo, Ole Schmeltz Sogaard, Martin Tolstrup +1 more 2023-02-21
11578331 Combination comprising immunostimulatory oligonucleotides Matthias Schroff, Kerstin Kapp, Alfredo Zurlo 2023-02-14
10604760 Combination comprising immunostimulatory oligonucleotides Matthias Schroff, Kerstin Kapp, Alfredo Zurlo 2020-03-31
10487333 Combination comprising immunostimulatory oligonucleotides Matthias Schroff, Kerstin Kapp, Alfredo Zurlo 2019-11-26
10006032 Predictive biomarker for cancer therapy Matthias Schroff, Kerstin Kapp, Burghardt Wittig 2018-06-26
9499815 Multimer for immunostimulation Matthias Schroff, Burghardt Wittig, Janine Loehr 2016-11-22
9375435 Use of a DNA expression construct Wolfgang Walther, Peter Schlag, Dennis Kobelt 2016-06-28
9345754 Allogeneic tumor therapeutic agent, a vaccine using allogeneic tumor cells for the therapeutic treatment of tumor diseases, and a method for the making of such a vaccine, and transfected human tumor cells for use as a vaccine Tomislav Dobric, Burghardt Wittig 2016-05-24
9212366 Immune modulating oligonucleotides in connection with chemotherapeutic measures Burghardt Wittig, Heribert Bohlen 2015-12-15
8017591 Substituted, non-coding nucleic acid molecule for therapeutic and prophylactic stimulation of the immune system in humans and higher animals Bernadette Brzezicha, Christiane Juhls, Florian Sack, Burghardt Wittig, Matthias Schroff 2011-09-13
7635468 Allogeneic tumor therapeutic agent, a vaccine using allogeneic tumor cells for the therapeutic treatment of tumor diseases, and a method for the making of such a vaccine, and transfected human tumor cells for use as a vaccine Tomislav Dobric, Burghardt Wittig 2009-12-22